Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Endogenous mono-ADP-ribosylation mediates smooth muscle cell proliferation and migration via protein kinase N-dependent induction of c-fos expression.
- L. Yau, Brenda Litchie, S. Thomas, Benjamin Storie, N. Yurkova, P. Zahradka
- Biology, Medicine
- European journal of biochemistry
- 13 December 2002
ADP-ribosylation has been coupled to intracellular events associated with smooth muscle cell vasoreactivity, cytoskeletal integrity and free radical damage. Additionally, there is evidence that… Expand
Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
- M. Moon, K. Molnar, L. Yau, P. Zahradka
- Medicine
- Journal of vascular surgery
- 1 July 2004
OBJECTIVE
Long-term success of revascularization procedures is limited by recurrent stenosis, a reduction in vascular lumen area that results from neointimal hyperplasia. Inhibitors of the… Expand
meta-Iodobenzylguanidine, an Inhibitor of Arginine-Dependent Mono(ADP-ribosyl)ation, Prevents Neointimal Hyperplasia
- L. Yau, P. Molnár, +6 authors P. Zahradka
- Medicine
- Journal of Pharmacology and Experimental…
- 1 September 2008
The association of ADP-ribosylation with cell proliferation and ischemia-reperfusion injury suggests that it may be a suitable target for therapeutic control of revascularization-induced injury. The… Expand
Immunodetection of activated mitogen-activated protein kinase in vascular tissues
- L. Yau, P. Zahradka
- Medicine
- Molecular and Cellular Biochemistry
- 2004
Mitogen-activated protein kinase (MAPK) is a key modulator of cytoplasmic-nuclear signal transmission, and for this reason measurement of MAPK activity has become very popular. Monitoring of MAPK… Expand
Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase.
- L. Yau, T. Elliot, C. Lalonde, P. Zahradka
- Biology, Medicine
- European journal of biochemistry
- 1 April 1998
Expression of the phosphoenolpyruvate carboxykinase (PEPCK) gene is induced by 3-aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase. Synthesis of PEPCK mRNA is repressed by insulin, but… Expand
Insulin-like growth factor-I (IGF-I)-dependent activation of pp42/44 mitogen-activated protein kinase occurs independently of IGF-I receptor kinase activation and IRS-1 tyrosine phosphorylation.
- L. Yau, H. Lukes, H. McDiarmid, J. Werner, P. Zahradka
- Chemistry, Medicine
- European journal of biochemistry
- 15 December 1999
The proliferation and metabolism of H4IIE hepatoma cells is apparently mediated through the insulin receptor. These cells, however, also have high-affinity binding sites for insulin-like growth… Expand
PGE2 stimulates vascular smooth muscle cell proliferation via the EP2 receptor
- L. Yau, P. Zahradka
- Biology, Medicine
- Molecular and Cellular Endocrinology
- 30 May 2003
Prostaglandins released by injured vascular tissue can modulate smooth muscle cell (SMC) proliferation. The mechanism of action of PGE(2) was investigated with porcine coronary artery SMCs obtained… Expand
Stimulation of protein synthesis by phosphatidic acid in rat cardiomyocytes.
- Y. Xu, L. Yau, L. Yu, V. Elimban, P. Zahradka, N. Dhalla
- Biology, Medicine
- Biochemical pharmacology
- 13 December 1996
Phosphatidic acid (PA) was observed to stimulate protein synthesis in adult cardiomyocytes in a time- and concentration-dependent manner. The maximal stimulation in protein synthesis (142 +/- 12% vs… Expand
Expression and regulation of the insulin-like growth factor-1 receptor by growing and quiescent H4IIE hepatoma.
- P. Zahradka, J. Werner, L. Yau
- Biology, Medicine
- Biochimica et biophysica acta
- 15 October 1998
Recent evidence that insulin-like growth factor-1 (IGF-1) influences certain properties of H4IIE hepatoma cells independent of insulin led us to examine whether H4IIE cells express IGF-1 receptors.… Expand
Inhibition of RNA synthesis by bradykinin involves both the B1 and B2 receptor subtypes.
- L. Yau, M. Pinsk, P. Zahradka
- Biology, Medicine
- Archives of biochemistry and biophysics
- 1 April 1996
The efficacy of angiotensin converting enzyme inhibitors in the treatment of heart disease is due in part to the accumulation of bradykinin (BK). Since BK can exert its effect by influencing cell… Expand